| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |